You are now leaving XTANDI.com
The website you are about to visit is not owned or controlled by Astellas. Astellas are not responsible for the information or services on this site.
NORTHBROOK, Ill. and BOGOTA, Colombia, June 23, 2016 /PRNewswire/ -- Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in Bogota. Colombia joins Astellas Farma Brasil as the company's second affiliate in Latin America.
Sandra Cifuentes has been appointed to general manager, AFC. She will be based in Bogota and report to Percival Barretto-Ko, senior vice president, International Operations. Cifuentes will have responsibility for managing and growing Astellas' operations in the third largest country in Latin America and fourth largest pharmaceutical market in the region.
"Today marks an important milestone for Astellas' continued growth in the Americas and we look forward to working with stakeholders across Colombia to serve the unmet needs of patients," said Barretto-Ko. "I'm confident that with Sandra's deep knowledge of Colombia, extensive leadership experience and notable commercial and market access achievements, Astellas will continue making a difference in the lives of patients."
Cifuentes brings more than 20 years of pharmaceutical experience in Latin America to Astellas. Most recently, she led Baxalta's (now Shire) business in Colombia, where she was responsible for driving strategy for the company's local affiliate following its spin-off from Baxter International. Prior to Baxalta, she served as general manager for Shire's Colombia and Andean region business, where she helped establish the company's Colombia affiliate. Since 2005, Cifuentes has also held numerous regional commercial roles of increasing responsibility at Novartis and Merck KGA in oncology, transplant, immunology, CNS and cardiovascular businesses.
Cifuentes holds degrees in nutrition and marketing from the Universidad Javeriana and Universidad de los Andes in Bogota, along with various executive certifications from the United States and Switzerland.
About Astellas
Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information on Astellas, please visit our website at www.astellas.us. You can also follow us on Twitter at @AstellasUS, Facebook at www.facebook.com/AstellasUS or LinkedIn at www.linkedin.com/company/astellas-pharma.
Photo - http://photos.prnewswire.com/prnh/20160621/382017
Logo - http://photos.prnewswire.com/prnh/20140416/84970
SOURCE Astellas
Get only the email alerts you want.
For media inquiries and reporter requests, please email us at corporate.communications@us.astellas.com.
Our communications team will respond to verified media requests within 24-48 hours as appropriate.
If you are not a reporter and need assistance, please visit our contact us page that includes information for patients, healthcare providers and researchers.
This website is intended for U.S. residents only. This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including those under development. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.
The site uses cookies to provide you with a more responsive and personalized service and to analyze site traffic. By using this site, you accept our use of cookies as described in our privacy policy. Please read our privacy policy for more information on the cookies we use, the processing of your personal data and how to delete or block the use of cookies.